German Company Curevac Is Rushing To Make A Covid-19 Vaccine | Nowthis

German Company CureVac is Rushing to Make a COVID-19 Vaccine | NowThis

Why is Germany's CureVac vaccine just 48% effective? | Covid-19 Special

COVID-19: Germany takes US$338m stake in biotech firm CureVac amid race for vaccine

CNA

Third mRNA COVID-19 vaccine CureVac on the cusp of announcing clinical trial results

Global race for Coronavirus vaccine | Germany buys 23% stake in CureVac

WION

European Commission strikes deal with German biotech firm CureVac for potential COVID-19 vaccine

US tries to lure German firm working on virus vaccine: Report

Al Jazeera English

CureVac CEO Daniel Menichella on efforts to produce a coronavirus vaccine

CNBC Television

Germany's BioNTech, CureVac joins coronavirus vaccine race | COVID-19 | World News

WION

CureVac strikes COVID vaccine alliance with Bayer

CureVac's COVID-19 vaccine suitable for standard refrigeration

47% efficacy: Did Germany's CureVac vaccine ultimately fail? | DW News

CureVac COVID-19 vaccine shows immune response in clinical trial

CureVac Will Make the Next-Gen Covid Shot

Bloomberg Television

German biotech firm starts human trials of experimental COVID-19 vaccine | WION-DW Partnership

WION

EU funds #CureVac firm developing virus vaccine amid US interest #Coronavirus

EU Debates | eudebates.tv

EU and CureVac join forces in search for a coronavirus vaccine

EU Science & Innovation

CureVac CEO on the company's IPO and Covid-19 vaccine research

CNBC Television

CureVac working on a second generation vaccine to combat Covid variants, CEO says

CNBC International News

Enough Pharma Capacity to Vaccinate World by End of 2021: CureVac CEO

Bloomberg Television